Iterative coherent mapping of cardiac electrophysiological (EP) excitation with reentry effects

The iterative coherent electroanatomical mapping method addresses reentry and scar tissue in cardiac electrophysiological mapping, providing accurate arrhythmia identification and enhancing treatment success by remeshing heart chamber data and iteratively calculating local activation times.

JP7581594B2Active Publication Date: 2024-11-13BIOSENSE WEBSTER (ISRAEL) LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2019202151
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-11-08
Filing Date
2019-11-07
Publication Date
2024-11-13
Estimated Expiration
2039-11-07

AI Technical Summary

Technical Problem

Existing cardiac electrophysiological mapping methods fail to accurately account for reentry effects and scar tissue, leading to inaccurate identification of cardiac arrhythmias and potential misdiagnosis.

Method used

An iterative coherent electroanatomical mapping method that remeshes heart chamber data into regularized polygons, iteratively calculates local activation times and probabilities of scar tissue, and overlays electrophysiological excitation waves to create a coherent map that accounts for reentry and scar tissue.

Benefits of technology

Provides accurate and reliable mapping of cardiac arrhythmias, particularly supraventricular tachycardia, by eliminating rainbow artifacts and improving the success rate of invasive treatments like catheter ablation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581594000056
    Figure 0007581594000056
  • Figure 0007581594000057
    Figure 0007581594000057
  • Figure 0007581594000058
    Figure 0007581594000058
Patent Text Reader

Abstract

To provide methods and systems for cardiac electrophysiological mapping.SOLUTION: A method includes receiving an input mesh representation of a cardiac chamber, a set of measured locations on a wall tissue of the cardiac chamber, and a set of respective local activation times (LATs) measured at the locations. The input mesh is re-meshed into a regular mesh including regularized polygons. The set of measured locations and respective LATs are data-fitted to the regularized polygons. The respective LAT values are iteratively calculated for the regularized polygons, so as to obtain a cyclic EP activation wave solution over the regular mesh taking reentry of an EP wave into account. An electroanatomical map including the cyclic EP activation wave overlaid on the regular mesh is presented.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application is related to U.S. patent application filed on even date, Attorney Docket No. 1002-1854, entitled "ITERATIVE COHERENT MAPPING OF CARDIAC ELECTROPHYSIOLOGICAL (EP) ACTIVATION INCLUDING SCAR EFFECTS," the disclosure of which is incorporated herein by reference.

[0002] FIELD OF THEINVENTION The present invention relates generally to electrophysiological mapping, and more particularly to methods and systems for electrophysiological mapping of the heart. [Background technology]

[0003] Electrophysiological cardiac mapping is often used to identify potential causes of cardiac arrhythmias in cardiac tissue. For example, US Patent Application Publication No. 2017 / 0281031 describes electroanatomical mapping by inserting a multi-electrode probe into the heart of a living subject, recording electrograms from the electrodes simultaneously at each location in the heart, defining the extent of each respective excitation time interval in the electrogram, generating a map of electrical propagation waves from the excitation time intervals, maximizing wave coherence by adjusting local excitation times within the excitation time of the electrogram, and reporting the adjusted local excitation times.

[0004] As another example, US Patent Application Publication No. 2016 / 0106376 describes calculating local conduction velocity of a cardiac activation wavefront by collecting multiple electrophysiological (EP) data points, each of which includes both location data and local activation time (LAT) data, using a multi-electrode catheter. For any EP data point, a neighborhood of the EP data point can be defined that includes the selected EP data point and at least two additional EP data points. The locations and LATs of the EP data points in the neighborhood can be used to define multiple planes of location and LAT, respectively. From the intersections of the location and LAT planes, a conduction velocity can be calculated. The determined multiple conduction velocities can be output as a graphical representation (e.g., an electrophysiology map), for example, by displaying multiple vector icons arranged in a uniform grid on a three-dimensional heart model.

[0005] US Patent No. 6,301,496 describes a method for diagnosing an abnormal condition in a biological structure such as the heart, comprising the steps of measuring the physiological response of at least three sampling points on the surface of the biological structure, calculating a vector function associated with the response, displaying a representation of the vector function, and inferring the abnormal condition from the representation. The invention is particularly useful for diagnosing cardiac arrhythmias, where the physiological response is a voltage from which a local activation time is estimated, and the vector function is the gradient of the local activation time, specifically the conduction velocity. The magnitude of the conduction velocity is expected to be abnormally low in scar tissue. Summary of the Invention [Means for solving the problem]

[0006] One embodiment of the present invention provides a method that includes receiving a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber, and respective sets of local activation times (LATs) measured at those locations. The input mesh is remeshed into a regular mesh that includes a regularized polygon. The set of measurement locations and respective LATs are data-fitted to the regularized polygon. For the regularized polygon, respective LAT values ​​and respective probabilities that the wall tissue contains scar tissue are iteratively calculated to determine electrophysiological (EP) activation waves on the regularized mesh that are indicative of scar tissue. An electroanatomical map overlaid on the regularized mesh is represented, including the EP activation waves and the scar tissue.

[0007] In some embodiments, the regularized polygon comprises a regularized triangle.

[0008] In some embodiments, iteratively calculating the LAT values ​​and probabilities includes iteratively solving a set of equations for the LAT values, the slowness values ​​and the propagation of EP waves.

[0009] In one embodiment, iteratively calculating the probabilities includes reassigning a recalculated slowness vector to each regularized polygon using a scar weight multiplier.

[0010] In another embodiment, the method further comprises binary tagging at least some of the measurement locations to indicate at least one of the presence of a scar and the presence of a double EP potential.

[0011] In some embodiments, representing the electroanatomical map includes overlaying conduction arrows indicating the scar tissue on the electroanatomical map.

[0012] Further, according to an embodiment of the present invention, there is provided a system including an interface and a processor. The interface is configured to receive a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber and respective sets of local activation times (LATs) measured at these locations. The processor is configured to remesh the input mesh into a regular mesh including a plurality of regularized polygons, data-fit the set of measurement locations and respective LATs to the plurality of regularized polygons, and iteratively calculate for the regularized polygons (i) respective LAT values ​​and (ii) respective probabilities that the wall tissue includes scar tissue to determine electrophysiological (EP) activation waves on the regularized mesh indicative of scar tissue. The processor is further configured to represent an electroanatomical map including the EP activation waves and the scar tissue overlaid on the regularized mesh.

[0013] Another embodiment of the invention provides a method that includes receiving a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber, and a respective set of local activation times (LATs) measured at those locations.

[0014] The input mesh is remeshed into a regular mesh that includes a regularized polygon. The set of measurement locations and their respective LATs are data-fitted to the regularized polygon. For the regularized polygon, respective LAT values ​​are iteratively calculated to solve for periodic EP waves on the regular mesh that takes into account EP wave reentry. An electroanatomical map is represented that includes the periodic EP waves overlaid on the regular mesh.

[0015] In some embodiments, iteratively calculating the LAT value includes iteratively solving a set of complex-valued equations configured to describe the reentry of the EP wave by including a reentry cycle length value.

[0016] In some embodiments, iteratively calculating the LAT value includes iteratively solving a set of three linear equations for the LAT value, the slowness value, and the propagation of the EP wave.

[0017] In one embodiment, iteratively calculating the LAT values ​​includes reassigning a recalculated slowness vector to each regularized polygon using a proximity weight multiplier.

[0018] Further, according to an embodiment of the present invention, there is provided a system including an interface and a processor. The interface is configured to receive a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber and respective sets of local activation times (LATs) measured at these locations. The processor is configured to remesh the input mesh into a regular mesh including regularized polygons, data-fit the set of measurement locations and respective LATs to a plurality of regularized polygons, and iteratively calculate respective LAT values ​​for the regularized polygons to solve for periodic EP waves on the regular mesh taking into account reentry of the EP waves. The processor is further configured to represent an electroanatomical map including the periodic EP waves overlaid on the regular mesh.

[0019] The invention will be more fully understood from consideration of the following detailed description taken in conjunction with the drawings, in which: [Brief description of the drawings]

[0020] [Figure 1] FIG. 1 is a schematic, pictorial illustration of a cardiac three-dimensional (3D) navigation and electrophysiological (EP) signal analysis system, in accordance with an embodiment of the present invention. [Diagram 2] 1 is a flow chart that generally illustrates a method and algorithm for computing coherent EP excitation waves, in accordance with an embodiment of the present invention. [Diagram 3] 3 is a flow chart that illustrates generally a method and algorithm for calculating scar probability as part of the process described in FIG. 2, according to an embodiment of the present invention; [Figure 4]3 is a flow chart that generally illustrates a method and algorithm for generating an EP excitability wave map from the process described in FIG. 2, in accordance with an embodiment of the present invention. [Diagram 5] FIG. 2 is a schematic, pictorial illustration of a volume rendering of a coherent EP activation map of the left atrium taking into account EP wave reentry and scar tissue, in accordance with an embodiment of the present invention; [Figure 6] FIG. 2 is a schematic, pictorial illustration of a volume rendering of a coherent EP activation map of the left atrium overlaid with conduction arrows illustrating the propagation of EP activation waves, in accordance with an embodiment of the present invention; DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0021] Overview Cardiac arrhythmias are a type of condition in which the heart beats irregularly. An important group within this category are supraventricular tachycardia (SVT), which include atrial tachycardia, atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia. In SVT, as the name suggests, the arrhythmia originates in the atria of the heart.

[0022] A portion of SVT events have electrophysiological (EP) impairments due to scar tissue. For example, atypical atrial tachycardia events often occur in patients with ablation-related scar. In areas of scar tissue, EP excitation may be completely blocked or partially blocked (areas of slow conduction). These areas are hereafter referred to as "lines of block" or scar areas.

[0023] The embodiments of the present invention described below provide an iterative coherent electroanatomical (ICEA) mapping method and system for identifying potential arrhythmias belonging to the SVT family. In the context of the disclosed description, "coherent" means deriving a best-fitting EP excitation wave propagation description in which the conduction velocity is both periodic and continuous.

[0024] Thus, abrupt changes in excitation wave direction or abrupt changes in excitation wave velocity are mathematically disallowed, except for non-conducting regions such as scars where excitation is blocked by certain anatomical barriers or scar tissue. Thus, in addition to correctly capturing the continuous and periodic (i.e., excitation wave re-entry as described below) features of cardiac EP activation, the disclosed coherent mapping method generates EA maps that show scar regions of any shape (e.g., lines, etc.).

[0025] The disclosed coherent mapping method addresses the occurrence of excitation wave reentry, such as reentrant tachycardia (RT), in which the EP excitation wave travels in a circular fashion within the heart (i.e., periodic EP excitation waves occur) rather than terminating after traveling from one end of the heart to the other after crossing a physiological barrier (non-conducting anatomical structure), as described above. If the EP excitation wave propagates continuously with a constant cycle length (such as the time between successive peaks in an ECG), the wave propagation within the heart chamber may span an entire reentry cycle in which the "late" wave front of one cycle meets the "early" wave front of the next cycle. As a result, regions may be assigned erroneous local activation times (LATs) that are one cycle length apart, even though these wave fronts are close in time.

[0026] Since the disclosed ICEA method embodiments take into account wave reentry and thus overcome artifacts due to reentry in the EA map, ICEA is designed to work for most types of arrhythmias, but in some embodiments, the disclosed method is optimized for cases of atrial flutter (AFL) and other cases of macro-reentry. EA maps obtained in this manner of heart chambers that typically exhibit abnormal EP activity, e.g., due to the presence of AFL, represent such abnormal EP activity without the "rainbow" artifacts (described below) associated with reentry that would otherwise be caused by models that do not take EP wave reentry into account. Thus, such "rainbow" artifacts are eliminated by using the disclosed ICEA mapping method.

[0027] In some embodiments, the disclosed model receives a representation of an input mesh of the heart chamber, a set of measurement locations on the wall tissue of the heart chamber and a respective set of LATs measured at those locations, and the locations and respective LAT values ​​are hereinafter referred to as "data points." The processor re-meshes the input mesh into a regular mesh that includes regularized polygons, such as triangles, also hereinafter referred to as "faces." In some embodiments, the processor performs a data fit of the set of measured data points to the regularized polygons.

[0028] After the first iterative coherent solution is found, information indicative of discontinuities in an otherwise continuous ICEA map is used. For example, the processor utilizes user-provided tagging of data points indicative of normal tissue regions, scar tissue regions, or double potential tissue regions. In the disclosed description, double EP potentials are defined as specific double spikes identifiable in segmented multi-component electrograms recorded on the tissue walls of a cardiac chamber, such as the atrium.

[0029] In some embodiments of the invention, the processor further assigns to each face (i.e. triangle) a probability of being an electrically non-conductive region, i.e. scar tissue. The probability is assigned (either automatically or manually by the user) by considering whether the measurement point on the map is a normal, scar or dual potential measurement. The assignment may further include considering the LAT pattern and a slowness value. The slowness is the inverse of the magnitude of the EP signal velocity vector along the geodesic line connecting two adjacent faces, a vector whose direction is the same as the velocity vector as described below.

[0030] Once a surface is assigned a high probability of being non-conductive, a loose slowness continuity constraint and a loose boundary velocity constraint are applied to generate a map that takes into account the possible presence of scar tissue. Regions of slow conduction (including lines of block) are further identified by excitation waves with mutually opposing propagation vectors (i.e., anti-parallel conduction arrows on the ICEA map indicating a line of block between them), where the propagation vectors circle around the scar, indicating non-conductive tissue. In one embodiment, locations with low EP signal amplitudes are assigned a high probability of being part of the conduction barrier.

[0031] The processor estimates EP waves on a regular mesh containing a representation of the scar region by iteratively calculating the LAT values ​​and the probability (i.e., weight) of each face being conductive or part of the scar region. The iteratively calculated weights estimate the data that increases or decreases the likelihood that a face is scarred, and output the calculated scar probability for each face. The scar weights (i.e., scar probabilities) are then incorporated into the linear equations as multiplicative weights that reduce the strength of the equations of continuity in the block line regions. The same multiplicative weights also relax the constraint on slowness. This allows the solution in the block line regions to change more freely (e.g., abruptly). The processor performs the iterative calculations based on the assumption that EP waves are continuous unless they encounter a scar region.

[0032] The processor then generates a coherent activation map that describes EP activation waves that are typically at least partially abnormal due to, for example, the presence of scar. In one embodiment, the processor represents the generated ICEA map using a periodic color scale to reduce display reliance on "Early Meets Late," which causes the "rainbow artifact" described below. In another embodiment, the coherent EP activation map includes conduction arrows that indicate normal or abnormal propagation of EP activation waves.

[0033] Typically, the processor is programmed in software containing specific algorithms that enable the processor to perform each of the processor-related steps and functions described above.

[0034] The disclosed iterative coherent EP mapping method creates a mapping system that allows physicians to easily and reliably map and interpret complex arrhythmias. Thus, the disclosed system and method provide a tool that may increase the success rate of subsequent invasive cardiac procedures, such as catheter ablation.

[0035] System Description FIG. 1 is a schematic pictorial diagram of a three-dimensional (3D) navigation and electrophysiological (EP) signal analysis system 20 according to an embodiment of the present invention. The system 20 may be configured to analyze virtually any physiological parameter or combination of such parameters. In this specification, by way of example, it is assumed that the analyzed signal is the potential-time relationship of an intracardiac and / or extracardiac (surface) electrocardiogram (ECG). To fully characterize such a relationship, it is necessary to reference the signals to each other in time at various locations, as is done, for example, during LAT map generation. The time reference is achieved by measuring relative to a reference time (e.g., a time point), such as, for example, the start of each QRS complex (i.e., the start of each heart beat) of an ECG reference signal. In one embodiment, the reference signal is received from a catheter placed in the coronary sinus. In the case of SVT, the reference signal represents atrial activity, the frequency of which may be two or three times that of ventricular activity. A method for generating an LAT map is described in the aforementioned U.S. Pat. No. 9,050,011.

[0036] For simplicity and clarity, the following description assumes, unless otherwise noted, an investigation procedure in which the system 20 uses a probe 24 to measure actual electrical activity of the heart 34. The distal end 32 of the probe is assumed to have an electrode 22. The measured signals are used, among other things, to generate a LAT map of at least a portion of the wall tissue of the heart 34 of the patient 26.

[0037] Typically, probe 24 comprises a catheter that is inserted into the body of patient 26 during a mapping procedure performed by a physician 28 using system 20. During the procedure, patient 26 is assumed to be attached to a ground electrode 23. In addition, electrode 29 is assumed to be attached to the skin of patient 26 in the region of the heart 34.

[0038] In one embodiment, the probe 24 acquires a local intracardiac electrocardiogram (ECG) as it moves over a portion of the heart chamber. At the times when abnormal EP activation waves pass under the catheter electrodes, some features of the measured intracardiac ECG tracing are noted. At these times, the position of the probe 24 is also recorded.

[0039] System 20 may be controlled by a system processor 40, which includes a processing unit 42 in communication with a memory 44. In some embodiments, system processor 40 includes a memory 44 that stores a LAT and / or voltage map 62 of at least a portion of the wall tissue of heart 34 of patient 26. Processor 40 is typically mounted in a console 46, which includes operating controls 38, which typically include a pointing device 39, such as a mouse or trackball, used by physician 28 to interact with the processor.

[0040] The processor 40 (particularly the processing unit 42) executes software including the probe tracking module 30, the ECG module 36, and the EP excitation analysis module 35 to operate the system 20 and / or the EP excitation analysis module 35 to model arrhythmias and perform at least a portion of the disclosed analyses (e.g., using the LAT or adjusted LAT map 62 stored in memory 44).

[0041] An ECG module 36 is coupled to receive the actual electrical signals from electrodes 22 and 29. The module is configured to analyze the actual signals and is capable of presenting the results of the analysis on a display 48, typically in the standard ECG format of a graphical representation that varies over time.

[0042] The probe tracking module 30 typically tracks the position of the distal end 32 of the probe 24 within the heart of the patient 26. The tracking module may use any probe position tracking method known in the art. For example, the module 30 may operate a magnetic field-based position tracking subsystem. (For simplicity, components of such a subsystem are not shown in FIG. 1.)

[0043] Alternatively or additionally, tracking module 30 may track probe 24 by measuring the impedance between electrodes 23, 29 and 22, as well as the impedance to other electrodes that may be located on the probe. (In this case, electrodes 22 and / or 29 may provide both ECG and position tracking signals.) The Carto3® system, manufactured by Biosense Webster (Irvine, Calif.), uses both magnetic field position tracking and impedance measurements for position tracking.

[0044] The processor 40 can use the tracking module 30 to measure the location of the distal tip 32. Additionally, by using both the tracking module 30 and the ECG module 36, the processor can measure not only the location of the distal tip, but also the LAT of the actual electrical signal detected at these specific locations. As mentioned above, the electrical tracking signals from the individual electrodes 22 can be combined with the magnetic tracking signals such that the location of each electrode is recorded. Such hybrid (i.e. magnetic / electrical) tracking systems and methods, termed Advanced Current Location (ACL), have been implemented in various medical applications, such as the CARTO® system manufactured by Biosense-Webster Inc. and described in detail in U.S. Patent No. 8,456,182, the disclosure of which is incorporated herein by reference.

[0045] The results of the operations performed by processor 40 are displayed to physician 28 on display 48, which typically presents a graphic user interface to the physician, a visual representation of the ECG signals sensed by electrodes 22, and / or an image or map of the heart 34 under examination.

[0046] The software executed by processor 40 may be downloaded to processor 40 in electronic form, for example over a network, but alternatively or additionally, the software may be provided and / or stored on a non-transitory tangible medium, such as a magnetic, optical or electronic memory. In particular, processor 40 executes dedicated algorithms that enable processor 40 to perform the disclosed steps, as described below.

[0047] Iterative coherent mapping of cardiac EP activation including reentry and scar effects 2 is a flow chart that generally illustrates a method and algorithm for calculating coherent EP excitation waves, according to an embodiment of the present invention. The algorithm according to the present embodiment is executed by a processor 40.

[0048] Before describing steps 80-84 of the ICEA method in detail using the flow chart of FIG. 2, an overview of these steps will now be provided. In some embodiments, the disclosed method includes receiving an input three-dimensional (3D) mesh (i.e., a shape) that may model, for example, the atria of a heart. The 3D input mesh includes polygons, such as triangles (i.e., a triangular mesh). In some embodiments of the invention, a processor re-meshes the input mesh into a regular mesh that includes equilateral triangles (hereinafter also referred to as "faces"). The regular mesh allows for defining and iteratively solving a set of linear equations that maintains the continuity of the EP waves, and also reduces the computational effort, as described below.

[0049] The disclosed method further includes receiving a set of data points including measurement locations on the atrial wall tissue and a respective set of local activation times (LATs) measured at those locations. In some embodiments, the set of data points are measured using a catheter-based electroanatomical mapping system such as CARTO® using a mapping catheter such as the PENTARAY® or LASSO® (both the system and catheter are manufactured by Biosense-Webster, Irvine, Calif.).

[0050] In some embodiments, the disclosed method uses as input an anatomical map obtained using Fast Anatomical Mapping (FAM) techniques. The processor 40 may discard information in the map other than the anatomical structures themselves, thereby allowing the disclosed method to use as input anatomical maps electroanatomical maps that are more useful for the disclosed method (e.g., the input electroanatomical map of the heart chambers that is used is the original mesh of the heart chamber shape).

[0051] In some embodiments of the invention, the processor discards some of the received data points (i.e., the measurement positions and their respective LATs) and / or performs data fitting on some of the data points so that they match the disclosed regular mesh.

[0052] In one embodiment, processor 40 uses a technique called Tissue Proximity Index (TPI) to discard data points determined to have been acquired while the mapping electrodes were not in physical contact with tissue.

[0053] In another embodiment, the processor adjusts measurement locations that do not otherwise fit a realistic description of the anatomy provided by the regular mesh. In this way, the disclosed coherent mapping method overcomes errors in catheter-measured locations, such as errors due to the catheter exerting forces on the AV wall, distorting its shape (forces applied to bring the electrodes acquiring the EP signals into good contact with the tissue), or due to respiratory motion unrelated to changes in the catheter location on the AV wall.

[0054] The processor then uses the inputs, i.e., the measured positions and their respective LATs, and the input mesh remeshed into triangular faces. In one embodiment, the disclosed model assumes that the EP excitatory waves between two adjacent faces propagate along a geodesic on the shape connecting the centers of the faces in the direction of their slowness vector. Thus, the time difference between the centers of the faces is the geodesic distance between them multiplied by the slowness vector.

[0055] The model further assumes that the EP wave is continuous and that adjacent planes must have similar slowness vectors. The model further assumes that the conduction velocity of the EP wave is between expected minimum and maximum velocities (i.e., within the range of velocities known for normal myocardium).

[0056] The disclosed model formulates the above assumptions in a set of linear equations under boundary conditions. The processor first solves the equations non-iteratively to obtain an initial estimate of coherent EP activation waves overlaid on the shape. The ICEA model may be recalculated based on the accumulation of supporting data such as local velocity vectors so that the EP activation map continues to change as data is collected. In one embodiment, the disclosed ICEA calculation is initiated by the user, usually after all EP data has been acquired. If new EP data is added, the user restarts the calculation from the beginning with the initial non-iterative solution.

[0057] The processor then uses the initial solution to iteratively solve a set of linear equations in a least-squares fashion aimed at finding the "optimal" EP activation, based on the further assumption that the measured LAT value of each surface affects the LAT value of the adjacent surface as a function of the distance from the measurement point to the center of the adjacent surface. The iterative calculations result in a globally optimal solution consisting of the derived EP activation waves overlaid on the shape. The number of iterations, typically up to a few, is a pre-set parameter based on visual inspection of a large number of EA maps during the development phase, such that no obvious changes in the solution occur beyond a pre-defined number of iterations. The user initiates the calculation and typically receives the complete ICEA map within a few seconds.

[0058] The process begins with an upload step 80 where the processor 40 uploads inputs for the method, which include (i) a 3D mesh (triangular) representing the heart chamber walls, (ii) a set of measured data points (e.g., location and LAT), (iii) atrial flutter cycle length t, as shown in inset 280. cl and (iv) tagged locations such as scar, double potential, etc. In some embodiments, steps (iii) or (iv) are not required, for example, if the following calculations do not consider reentry or do not include scar-related calculations.

[0059] Next, in an equation construction step 81, processor 40 assigns two variables to each face (i.e., triangle) in the mesh: a LAT value and a slowness vector. To construct a set of equations for the two variables, the method makes three assumptions that affect the two variables: 1. EP excitation waves are continuous, and adjacent planes must have similar slowness vectors. 2. The measured LAT value on a given surface affects the calculated LAT of adjacent surfaces as a function of the distance from the measurement location to the center of gravity of the adjacent surface. 3. The equation of propagation of an excitatory wave is maintained as disclosed, where the wave propagates between multiple faces in the direction of its slowness vector, and the time difference between the centers of the faces is the geodesic distance between them multiplied by the slowness vector.

[0060] The above assumptions lead to a set of linear equations:

[0061]

number

[0062]

number

[0063] In Equation 1, Equation (I) decays exponentially with the distance between the measurement location and the surface location used, decreasing in influence as the distance from the regular shape increases.

[0064]

number

[0065]

number

[0066] Equation (II) is a complex-valued slowness vector that handles reentry via a rotation matrix R(j,i), as described below.

[0067]

number

[0068] Equation (III) is a propagation equation that states that a wave propagating between two adjacent surfaces should have a slowness and LAT that are related by the distance between the surfaces. Because the equation is written in terms of two adjacent surfaces, it reflects the relationship between all LAT and slowness vectors associated with all surfaces in the shape.

[0069] Equations 1(I)-(III) apply the following relationships:

[0070]

number

[0071] The relationship in Equation 2 is that all time scales are short.

[0072]

number

[0073] The complex form of the periodic wave as a function of time takes into account the occurrence of reentry, where the excitation wave propagates continuously with a constant cycle length.

[0074] Equation 1(II) is the equation for continuous propagation (similarity), and two adjacent surfaces have similar slowness vectors.

[0075]

number

[0076]

number

[0077]

number

[0078] Equation 1(III) describes the propagation of a periodic EP wave between surfaces. The distance traveled by the wave front is the projection of the geodesic distance, which is the distance between the centers of gravity of the two surfaces,

[0079]

number

[0080] In a first equation solving step 82, the processor 40 non-iteratively solves Equation 1 to obtain an initial estimate of the EP excitation wave. In one embodiment, Equation 1 is solved using the least squares method. The solution is performed using mathematical techniques from numerical linear algebra including Cholesky decomposition followed by forward and backward substitution as described in Trefethen, LN, Bau, D., Numerical Linear Algebra (1997), pp. 172-178, published by SIAM Publishing House.

[0081] In one embodiment, terms (I), (II), and (III) of Equation 1 are combined into a single sparse matrix equation. Different optimization weights can be assigned to each sub-equation (i.e., term) to balance various influencing factors. These optimization weights can be different between iterations. These optimization weights are also preset parameters, such as the number of iterations.

[0082] In an initial guess, the physical meaning of the slowness vector is that it represents the change in complex phase of time with distance. This is in contrast to the usual slowness vector, which represents the change in time with distance. Since slowness is a complex number, it has a different physical definition and is somewhat unnatural.

[0083] Solving equation 1 in the complex domain allows us to deal with periodic excitations in a natural way and eliminates complications due to the Early Meets Late effect. To obtain a physically meaningful expression of the slowness, an additional step of constructing and solving a set of iterative equations is required.

[0084] Solving the complex function allows for a straightforward calculation of the periodic excitation, but it should be noted that to preserve the physical meaning of the slowness vector, the complex slowness must be converted back to a real value. Thus, finally,

[0085]

number

[0086]

number

[0087]

number

[0088] The disclosed method includes, in an iterative equation construction step 83, iteratively solving Equation 1 using the initial guesses determined in step 82:

[0089]

number

[0090]

number

[0091]

number

[0092] In one embodiment, the real linearized Equation 1, i.e., Equation 4, is i ,

[0093]

number

[0094]

number

[0095]

number

[0096] The conduction velocity of each plane is calculated based on the measured activation time, the calculated propagation vector, and the known distance between the centers of each plane. Under some conditions, the linear solution may produce regions of slowness vectors (also called "sources" or "sinks") that are close to zero. Such regions are not realistic, since they imply locations with infinite velocity. A constraint is added to make the EP conduction velocity approximate some positive physiological constant a:

[0097]

number

[0098] Equation 5 "penalizes" large velocities (small slowness) deviations from a. After Taylor expansion,

[0099]

number

[0100]

number

[0101] The constraint in equation 6 is

[0102]

number

[0103]

number

[0104]

number

[0105] Next, in an iterative solution step 84, the processor 40 calculates the variable Re(Δφ i ),Im(Δφ i ),

[0106]

number

[0107] In steps 81-84, Equation 4 is solved assuming continuous propagation of the excitation wave. Incorporating scar information into the solution requires a framework for detecting scars and for creating discontinuities in the EP excitation wave (i.e., the solution) at block lines and non-conducting regions.

[0108] The disclosed coherent mapping method assigns smaller weights to constraints that cause the solution to be non-coherent (i.e., inconsistent or discontinuous). Thus, measured LAT values ​​that the processor determines to be invalid (i.e., outlier LAT values) are removed by the processor during an iteration. The method assigns new weights after receiving the solution vector for an iteration. In the case of LAT constraints, the process removes inconsistent points. In the case of neighbor constraints, the process removes inconsistent edges.

[0109] Next, we provide an overview of steps 85-90 of the ICEA method before describing these steps in detail using the flowchart in Figure 2. The framework is also built on an iterative method, but here we introduce the scar weight introduction step 85, which introduces the scar (face) weights.

[0110]

number

[0111] The iteratively calculated weights estimate the data that increases or decreases the likelihood that a face is a scar, and output the calculated scar probability for each face. Next, the scar weights (i.e., scar probability)

[0112]

number

[0113] First, in Equation 4(II) of the propagation, we add two weights of the two faces adjacent to edge (I,j).

[0114]

number

[0115]

number

[0116] This is because conduction between the surfaces may be impaired if any of these surfaces are already showing signs of scarring (i.e. small

[0117]

number

[0118] Therefore, in regions where scarring is detected, the weighting in Equation 40(II) for continuous propagation is reduced, which relaxes the requirement of slowness similarity between adjacent faces and allows for discontinuous wave propagation in scarred regions.

[0119] The normalized slowness and velocity equation (Equation 6) is then multiplied by the calculated weights, thus reducing the size requirement for the target velocity with scar surface:

[0120]

number

[0121] After the scar probability has been integrated into the equation, processor 40 solves the modified Equation 4 in a scar weight integration step 87, and the new solution is presented in a LAT and slowness output step 89. A new, more accurate scar probability is then calculated in step 100, up to a predetermined number of iterations that are verified to produce a sufficiently accurate map, such as the coherent EP excitation map described in FIG.

[0122] Figure 3 is a flow chart that illustrates, in accordance with one embodiment of the present invention, a schematic of a method and algorithm for calculating scar probability as part of the process described in Figure 2. Figure 3 describes the different modules (i.e. computational sub-steps) involved in step 100 that may cause discontinuities in the EP excitatory wave solution at lines of blocks and non-conducting regions. The algorithm according to this embodiment is executed by a processor 40.

[0123] Step 100 includes computational modules (or steps) 91-98 that estimate data for each face of a triangle of the mesh that increases or decreases the likelihood that the face represents a scar. The output of each of steps 91-98 is a weight ranging from 0 to 1. The weights lie in the range [0,1], with 1 indicating a normal face and 0 indicating a scar or "slow conducting" face (there is no distinction between the two in the current version).

[0124] As described below, the weights calculated in steps 92-96 are arranged in the form of a matrix of a cost function, and step 99 calculates the scar weights by minimizing the cost function.

[0125]

number

[0126]

number

[0127] In a boundary region weighting step 92, processor 40 weights the faces of the boundary regions indicative of the gradient of the variance of the LAT from nearby measurements.

[0128]

number

[0129] In a large slowness weighting step 93, processor 40 calculates a slowness weight that indicates whether a face has a large slowness vector.

[0130]

number

[0131] In a LAT-related weighting step 94, processor 40 weights the difference between the measured LAT and the calculated surface LAT. This is called the measured surface weighting.

[0132]

number

[0133]

number

[0134] In a scar-related weighting step 95, the processor 40 assigns weights reflecting the "link strength" between scar measurement point i and face j.

[0135]

number

[0136] At a single scar density weighting step 96, the processor 40 calculates a single scar density weighting which indicates areas where a single scar measurement is surrounded by regular (non-scar) measurements.

[0137]

number

[0138] The different weights calculated in steps 92-96 are processed by a scar information estimation integration module 99 which calculates a scar probability for each face. The scar probability is then incorporated into the iterative calculation step 87 to reduce the strength of the continuity equation in the block line region, as shown in Figure 2. Additionally, the relative strength of the slowness norm and velocity norm equations are also reduced as described above. This allows the solution to vary more freely in the block line region.

[0139] Step 99 calculates the scar probability weight for each face by formulating the following rule into a cost function: 1. Continuous scar / slow conduction areas. 2. A scar-tagged measurement means there is a scar nearby. 3. Areas with many measurement points in close proximity are conductive. 4. Weight or double potential tagged measurements of large border areas indicate scar borders. 5. Areas with little surrounding information, i.e., no measurement points nearby, are more likely to be scars. 6. Areas of high slowness close to scar-tagged measurements have a higher probability of being scar.

[0140] The computed cost is defined as the sum of a quadratic term and a linear term:

[0141]

number

[0142]

number

[0143]

number

[0144] The quadratic cost term in Equation 9 is defined as:

[0145]

number

[0146] H reflects the continuity of scar probability, meaning that adjacent faces should have similar scar probability, with the goal of linking fragmented scar regions.

[0147] L is a vector of linear cost terms associated with each facet. It consists of two contradictory terms: one term contains all the information that indicates a scar, and the other term contains all the information that indicates a normal facet.

[0148] Then the linear cost vector is defined as:

[0149]

number

[0150] Linear terms on each surface

[0151]

number

[0152] This term is added to the quadratic term (Equation 11) to obtain the final cost function. The optimizer uses the weights w sf The weight w sf is 1 to indicate a conductive surface and 0 to indicate a block.

[0153] For example, if f is 0.5, the scar and normal scores for the face are

[0154]

number

[0155]

number

[0156]

number

[0157]

number

[0158] The processor 40 calculates a total cost function using quadratic programming.

[0159]

number

[0160]

number

[0161]

number

[0162] As described by Florian A. Potra and Stephen J. Wright in "Interior-point methods" (Journal of Computational and Applied Mathematics, Volume 124, issues (1-2), pp. 281-302 (2000)), this problem is solved using interior-point convex optimization. The output of this module is the weight of the scar face, which is the probability that face i is successfully incorporated in step 87.

[0163]

number

[0164] The exemplary flowchart shown in Figure 3 is chosen solely for the purposes of conceptual clarity, e.g., further implementation details are omitted for ease of presentation.

[0165] FIG. 4 is a flow chart that shows a schematic of a method and algorithm for generating an EP activation wave map from the process described in FIG. 2 according to an embodiment of the present invention. The algorithm according to this embodiment executes a process that starts with the processor 40 receiving a three-dimensional mesh representation 299a of the heart chamber in an input mesh receiving step 299. As shown, the mesh 299aa includes irregular triangular faces. Meshes such as the mesh 299a, which includes triangles with large and small sides, typically generated by the FAM technique described above, cause errors in the geometric approximation performed by the disclosed method. Next, in an input mesh regularization step 300, the processor 40 re-meshes the input mesh 299 to generate a more regular mesh 300a. The re-meshing is also performed with the aim of optimizing the computational steps used by the disclosed method according to the needs of EP wave estimation. In one embodiment, the mesh resolution (number of triangles) determines the number of equations to be generated (e.g. as done for matrices of a given size). Step 300 reduces the computational effort described in FIG. 2 and FIG. 3 by reducing the number of equations.

[0166] Next, in a mesh data fitting step 302, the processor 40 virtually transforms some of the triangle centers to better fit nearby measurement locations, without compromising the reconstruction. Step 302 is necessary because during the data acquisition from which the mesh is created, the mapping catheter tends to push against the atrial wall, producing a "distended" reconstruction shape. Many of the measurements are far away from the reconstruction, creating uncertainty in relating the measurement locations to the shape of the heart chamber.

[0167] 2 and 3 using a special purpose algorithm to derive LAT, slowness and scar probability values ​​for each face of the optimized triangular mesh. Typically, scar weights are not updated every time the LAT and slowness values ​​are updated.

[0168] Next, in a projection step 304, processor 40 projects the values ​​determined in step 302 onto the original mesh 299a. As described above, the EP excitatory waves are calculated on a simplified mesh. The disclosed method nevertheless provides a coherent map determined from the original mesh. A map is defined at each center of a face in the case of the low resolution mesh. Processor 40 maps faces of the high resolution map (of input map 299a) to points on the low resolution mesh by shooting rays inwards and outwards from the high resolution mesh in the direction normal to the faces.

[0169] If only one ray hits the low resolution mesh, processor 40 selects that point as the associated point on the low resolution mesh. If rays in both directions hit the mesh, processor 40 selects the closest point.

[0170] Processor 40 then interpolates the LAT values ​​in the faces of the low-resolution mesh at the points where the rays hit and assigns this value to the faces of the high-resolution mesh. In one embodiment, processor 40 omits LAT information for tissue regions where the number of acquired data points is less than a predetermined required value. Thus, such tissue regions where the EP mapping yields too sparse a mapping are "greyed out" in the resulting visualization.

[0171] Per step 304, the processor 40 generates a coherent EP excitability wave map 400, which is illustrated in FIG.

[0172] An important step in understanding arrhythmia flutter is the ability to display wave cycles throughout the mesh. Visualizing a 3D mesh on a 2D screen presents challenges such as seeing behind the mesh and determining anterior and distal portions of the mesh. In an isochrone generation step 410, processor 40 image processes map 400 into isochrone 500.

[0173] Isochrone 500 is a contour map 500a, where each contour is a curve with a constant LAT. Isochrone 500a shows an anterior-posterior (AP) view of the left atrium as an example. In practice, the map is color-coded.

[0174] The map 500a is transparent, allowing the user to view the entire span of the wave cycle while easily distinguishing between forward and distal components. Furthermore, this view allows for a better understanding of arrhythmias as the cycle through the structure can be easily followed. The contour intervals are equidistant in time, so the wave propagation speed is evident from the density of the curves. Areas of high contour density represent slower propagation and areas of low density represent faster propagation. Scar areas are shown as uniform areas without contours.

[0175] The exemplary flow chart shown in Figure 4 has been chosen solely for purposes of conceptual clarity, and exemplary graphical outputs of some steps, such as step 302, have been omitted for ease of presentation.

[0176] 5 is a schematic pictorial illustration of a volume rendering of a coherent EP activation map 400 of the left atrium taking into account EP wave reentry and scar tissue, in accordance with an embodiment of the present invention. As shown, the map 400 shows a realistic and continuous EP activation pattern in the region 210, as the rainbow artifacts mentioned above are suppressed by the disclosed method. As expected, there is a clear discontinuity between the EP conduction region 210 and the non-conducting scar region 220.

[0177] Inset 150 of FIG. 5 is a volume rendering of an interpolation of a color representation of EP excitation on the left atrium, calculated without the disclosed technique, for reference. In the example shown in inset 150, wave reentry is not considered. As a result, a "rainbow" artifact 155 appears, as seen in the inset. In the example shown in the inset, the EP wave propagation in the heart chamber spans a full reentry cycle where a "late" wave front in one cycle meets an "early" wave front in the next cycle. In this example, tissue regions are assigned LATs that are one cycle length apart. The narrow rainbow-like multi-shaded paths, when colored, show one cycle-long transitions between adjacent regions, thus causing map discontinuities that embodiments of the present invention eliminate, as described above. That is, the rainbow artifact described above is completely eliminated using the disclosed ICEA method.

[0178] In some embodiments, a cyclic color scale is used to eliminate the dependency on "Early Meets Late" within a window of interest (WOI). Colors represent relative time differences relative to a reference electrogram, eliminating the concept of "Early Meets Late." The color circle represents the activation pattern, so red does not represent early and purple late, as is the case with standard maps, for example. The color circle represents the proportionality of activation times in a natural cyclical way that does not result in rainbow transitions.

[0179] Figure 6 is a schematic pictorial diagram of a volume rendering of a coherent EP activation map 440 of the left atrium overlaid with conduction arrows 330 showing the propagation of EP activation waves, according to an embodiment of the present invention. The conduction arrows 330 are all fixed length vectors, each with a direction of their respective slowness vector at a geometric location that provides further visualization of the EP activity. For example, the conduction arrows 330 are typically displayed to encircle scar regions. In another embodiment (not shown in Figure 6), the conduction arrows have different lengths that represent the size of the slowness in addition to their direction.

[0180] It will be understood that the above-described embodiments are given by way of example, and that the present invention is not limited to what has been particularly shown and described above. Rather, the scope of the present invention includes both combinations of the various features described above and subcombinations thereof, as well as variations and modifications thereof that would occur to a person skilled in the art upon reading the above description and that are not disclosed in the prior art. Documents incorporated by reference into this patent application are to be considered as part of this application, except that if any term is defined in these incorporated documents in a manner that is inconsistent with the definition expressly or impliedly given herein, then only the definition in this specification shall be taken into consideration.

[0181] [Embodiment] (1) receiving an input mesh representation of a heart chamber, a set of measurement locations on wall tissue of the heart chamber, and respective sets of local activation times (LATs) measured at the locations; remeshing the input mesh into a regular mesh comprising regularized polygons; data-fitting the set of measurement locations and their respective LATs to the regularized polygon; Iteratively calculating the LAT value of each of the regularized polygons to obtain a solution of periodic EP excitation waves on the regular mesh taking into account reentry of EP waves; representing an electroanatomical map including the periodic EP activation waves overlaid on the regular mesh; A method comprising: (2) The method of embodiment 1, wherein iteratively calculating the LAT value comprises iteratively solving a set of complex-valued equations configured to describe the reentry of the EP wave by including a reentry cycle length value. (3) The method of embodiment 1, wherein iteratively calculating the LAT value includes iteratively solving a set of three linear equations for the LAT value, the slowness value and the propagation of the EP wave. (4) The method of embodiment 1, wherein iteratively calculating the LAT values ​​includes reassigning a recalculated slowness vector to each regularized polygon using a proximity weight multiplier. (5) an interface configured to receive a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber, and respective sets of local activation times (LATs) measured at the locations; 1. A processor comprising: remeshing the input mesh into a regular mesh comprising regularized polygons; data-fitting the set of measurement locations and their respective LATs to the regularized polygon; Iteratively calculate the LAT values ​​of each of the regularized polygons to obtain a solution of periodic EP excitation waves on the regular mesh taking into account reentry of EP waves; 13 represents an electroanatomical map including the periodic EP excitation waves overlaid on the regular mesh. a processor configured to A system comprising:

[0182] (6) The system of embodiment 5, wherein the processor is configured to iteratively calculate the LAT value by iteratively solving a set of complex-valued equations configured to describe reentry of the EP wave by including a reentry cycle length value. (7) The system of embodiment 5, wherein the processor is configured to iteratively calculate the LAT value by iteratively solving a set of three linear equations for the LAT value, the slowness value, and the propagation of the EP wave. (8) The system of embodiment 7, wherein the processor is configured to iteratively calculate the LAT value by reassigning a recalculated slowness vector using a proximity weight multiplier to each regularized polygon.

Claims

1. an interface configured to receive a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber, and respective sets of local activation times (LATs) measured at the locations; 1. A processor comprising: remeshing the input mesh into a regular mesh comprising regularized polygons; data-fitting the set of measurement locations and their respective LATs to the regularized polygon; Iteratively calculating LAT values ​​for each of the regularized polygons to obtain a solution of periodic EP excitation waves on the regular mesh that takes into account reentry of EP waves; 13 represents an electroanatomical map including the periodic EP activation waves overlaid on the regular mesh. a processor configured to Equipped with The system, wherein the processor is configured to iteratively calculate the LAT value by iteratively solving a set of complex-valued equations configured to describe reentry of the EP wave by including a reentry cycle length value.

2. 2. The system of claim 1, wherein the processor is configured to iteratively calculate the LAT value by iteratively solving a set of three linear equations for the LAT value, the slowness value, and the propagation of the EP wave.

3. 3. The system of claim 2, wherein the processor is configured to iteratively calculate the LAT value by reassigning a recalculated slowness vector to each regularized polygon using a proximity weight multiplier.

4. An interface comprising: receiving a representation of an input mesh of a heart chamber, a set of measurement locations on wall tissue of the heart chamber, and respective sets of local activation times (LATs) measured at the locations; The processor: remeshing the input mesh into a regular mesh comprising regularized polygons; data fitting the set of measurement locations and their respective LATs to the regularized polygon; Iteratively calculating the LAT values ​​for each of the regularized polygons to obtain a solution of periodic EP excitation waves on the regular mesh taking into account reentry of EP waves; representing an electroanatomical map including the periodic EP activation waves overlaid on the regular mesh; [0023] A method of operating a medical device, wherein iteratively calculating the LAT value includes iteratively solving a set of complex-valued equations configured to describe reentry of the EP wave by including a reentry cycle length value.

5. The method of claim 4, wherein iteratively calculating the LAT value comprises iteratively solving a set of three linear equations for the LAT value, the slowness value and the propagation of the EP wave.

6. The method of operating a medical device as described in claim 4, wherein iteratively calculating the LAT values ​​includes reassigning a recalculated slowness vector to each regularized polygon using a proximity weight multiplier.

Citation Information

Patent Citations

  • Non-contact cardiac mapping including catheter movement and multi-beat integration

    JP2009539566A

  • Removal of artifacts from map data

    JP2014124533A

  • Methods and systems for identifying and mapping cardiac activation wavefronts

    JP2018526107A

  • Computational localization of fibrillation sources

    WO2017112910A1